Results 221 to 230 of about 53,160 (273)
Photoacoustic Imaging in Inflammatory Orthopedic Diseases: Progress toward Precise Diagnostics and Predictive Regulation
Advanced Science, Volume 12, Issue 14, April 10, 2025.With the intensification of aging issues, inflammatory orthopedic diseases almost occurs in every elderly people, which are becoming increasingly severe. Persistent inflammation of joints often leads to irreversible tissue damage and loss of organ function, while early diagnosis and timely intervention are crucial for reducing the personal and social ...Mengyi Huang, Haoyu Yu, Rongyao Gao, Yuxin Liu, Xuhui Zhou, Limin Fu, Jing Zhou, Luoyuan Li +7 morewiley +1 more sourceAnimal models of human herpesvirus infection
Animal Models and Experimental Medicine, Volume 8, Issue 4, Page 615-628, April 2025.Human herpesvirus can infect humans and other vertebrates, primarily targeting the skin, mucous membranes, and neural tissues, thereby significantly impacting the health of both humans and animals. Animal models are crucial for studying virus pathogenesis, vaccine development, and drug testing.Ziqing Jia, Dong Zhang, Lin Zhu, Jing Xue +3 morewiley +1 more sourceRheumatic fever and long-term use of benzathine penicillin as possible risk factors for extensive macular atrophy with pseudodrusen in a Brazilian cohort. [PDF]
Int J Retina VitreousMoreira-Neto CA, Schmidt Andujar RA, Chao JCT, Vasconcelos H, Alves FEE, Rodrigues GD, Hirt B, Arana J, Souza EC, Maia A, Sallum JMF, Moreira CA. +11 moreeuropepmc +1 more sourceClinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project
Arthritis &Rheumatology, Volume 77, Issue 4, Page 477-489, April 2025.Objective
Anti‐synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with ASSD that may be suitable for inclusion in the data‐driven classification criteria for ASSD. Methods
We used a large,Sara Faghihi‐Kashani, Akira Yoshida, Francisca Bozan, Giovanni Zanframundo, Davide Rozza, Aravinthan Loganathan, Eduardo Dourado, Gianluca Sambataro, Iazsmin Bauer‐Ventura, Sangmee Sharon Bae, Darosa Lim, Daphne Rivero‐Gallegos, Yasuhiko Yamano, Albert Selva‐O'Callaghan, Andrew L. Mammen, Carlo A. Scirè, Carlomaurizio Montecucco, Chester V. Oddis, David Fiorentino, Francesco Bonella, Frederick W. Miller, Ingrid E. Lundberg, Jens Schmidt, Jorge Rojas‐Serrano, Marie Hudson, Masataka Kuwana, Miguel Angel González‐Gay, Neil McHugh, Tamera J. Corte, Tracy Jennifer Doyle, Victoria P. Werth, Latika Gupta, Diana Isabel Perez Roman, Lorenzo M. Bianchessi, Phani Kumar Devarasetti, Samuel Katsuyuki Shinjo, Fabrizio Luppi, Ilaria Cavazzana, Siamak Moghadam‐Kia, Marco Fornaro, Elizabeth R. Volkmann, Matteo Piga, Jesus Loarce‐Martos, Giacomo De Luca, Johannes Knitza, Veronica Wolff‐Cecchi, Marco Sebastiani, Adam Schiffenbauer, Lisa G. Rider, Raquel Campanilho‐Marques, Lucian Marts, Elena Bravi, Harsha Gunawardena, Rohit Aggarwal, Lorenzo Cavagna, on behalf of the Classification Criteria for Anti‐Synthetase Syndrome Project participating investigators, Anamika Anuja, Domenico Sambataro, Michele Colaci, Carlo Vancheri, Mayra Mejia, Pedro Abisay Rivera Matias, Francesca Bottazzi, Claudia Alpini, Liza Rajasekhar, Vikas Agarwal, Fernando Henrique Carlos De Souza, Renata Miossi, Maria Rosa Pozzi, Paola Faverio, Giovanni Franco, Giulia Dei, Franco Franceschini, David Lacomis, Florenzo Iannone, Francesco Girolamo, Ernesto Trallero‐Araguás, Albert Gil‐Vila, Ana Villar, Christina Charles‐Schoeman, Heather Bukiri, Chiara Murru, Alberto Cauli, Javier Bachiller‐Corral, Lorenzo Dagna, Corrado Campochiaro, Jorg Distler, George Schett, Matias Florenzano, Felipe Reyes, Antony Amato, Paul Dellaripa, Silvana Saavedra, Karen Vergara, Andreina Manfredi, Caterina Vacchi, Teresa Melo, Prateek Gandiga, Dhruv Amratia, Eugenio Arrigoni, Yuko Kaneko, Konstantinos Triantafyllias, Anna Mandel, Santos Castañeda, Esther Francisca Vicente‐Rabaneda, Océane Landon‐Cardinal, María Laura Alberti, Fabian Caro, Martín Gerardo Greco Merino, Iñigo Rua‐Figueroa, Christoph Fiehn, Jutta Bauhammer, Yair Molad, Osnat Klein, Marcello Govoni, Ran Nakashima, Erkan Alpsoy, Alain Meyer, Margherita Giannini, Hector Chinoy, James Lilleker, Laure Gallay, Vincent Cottin, Philippe Dieudè, Julien Campagne, André Pinto Saraiva, Edoardo Conticini, Giandomenco Sebastiani, Laura Nuno, Salvatore Scarpato, Elena Schiopu, Pier Paolo Sainaghi, Vega Jovani, Simone Barsotti, Natsuka Umezawa, Merrilee Needham, Giovanni Cagnotto, Maria Giovanna Danieli, Paola Tomietto, Nair Perez Gomez, Massimiliano Limonta, Giovanni Barausse, Yasuhiro Kondo, Daniela Ghetie, Farah Tamirou, Pari Basharat, Stylianos Tomaras, Reinhard Edmund Voll, Helena Andersson, Julia Martinez Barrio, Matthias Schneider, Paola Parronchi, Antonella Notarnicola, Jose Cifrian +153 morewiley +1 more sourceEscherichia coli in the production of biopharmaceuticals
Biotechnology and Applied Biochemistry, Volume 72, Issue 2, Page 528-541, April 2025.Abstract
Escherichia coli has shouldered a massive workload with the discovery of recombinant DNA technology. A new era began in the biopharmaceutical industry with the production of insulin, the first recombinant protein, in E. coli and its use in treating diabetes. After insulin, many biopharmaceuticals produced from E. coli have been approved by the İbrahim İncir, Özlem Kaplanwiley +1 more source
